Back to DAVENPORT & Co LLC DAVENPORT & Co LLC

ELVELV
Showing 9 of 31 quarters

Position history for DAVENPORT & Co LLCDAVENPORT & Co LLC's holdings in ELEVANCE HEALTH INC

Yes. Davenport holds 384,435 shares of ELV (Elevance Health), worth $150M, as of its Q3 2026 13F filing. It reduced the position by 57,505 shares (-13.0%) from Q2 2026. Davenport has held ELV in every 13F on record since Q1 2019, 31 quarterly filings. ELV is 0.8% of Davenport's reported 13F portfolio.

Current Value

$150M

Current Shares

384,435

Total Value Change

+$54.4M

Total Shares Change

+200,874

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
384,435
-13.0%
$150M0.8%$388.82
0
2026-Q2
Decreased
441,940
-23.0%
$171.1M0.8%$385.05
0
2026-Q1
Decreased
574,012
-0.3%
$166.8M0.9%$290.30
0
2025-Q4
Decreased
575,783
-8.6%
$201.6M1.1%$345.49
0
2025-Q3
Increased
630,203
+128.0%
$203M1.1%$316.82
78
2025-Q2
Decreased
276,455
-1.9%
$107.1M0.6%$379.31
0
2025-Q1
Increased
281,874
+23.6%
$122.4M0.7%$422.30
52
2024-Q4
Increased
228,063
+24.2%
$84.1M0.5%$356.67
43
2024-Q3
Decreased
183,561
-24.6%
$95.6M0.5%$500.71
0

Other major holders of ELV: BlackRock Finance, Inc., VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used